Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced new dermatology data presented at the European Academy of Dermatology and Venereology (EADV) ...

Over the next 10– 15 years, the biosimilars industry is expected to explode as the patents on branded biologics begin to expire. Analysts agree that biosimilar market size will be fairly ...

From the creation of a regulatory pathway for biosimilars in the EU only three biologics experienced EU biosimilar competition until the launch of Remsima/Inflectra in 2013, and none have (as at ...

(MENAFN- GlobeNewsWire - Nasdaq) The Pharmaceutical industry has made significant strides in biosimilars and biologics, offering opportunities for innovation, growth, and enhanced patient access ...

Biosimilars offer a more affordable alternative ... As with many chronic illnesses, biologics are usually a long-term treatment. But the dosage and duration may vary depending on the patient ...

On Tuesday, MedImpact Healthcare Systems, the fifth-largest PBM by market share, announced it will add two Humira biosimilars to formularies while continuing to cover the brand name biologic.

NEWARK, Del, Aug. 27, 2024 (GLOBE NEWSWIRE) -- As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has secured market entry for its proposed biosimilar to Stelara in Europe, the UK, Canada, and Japan. The company announced today ...

BENGALURU, India, Aug. 29, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced ...

BENGALURU, India, Aug. 29, 2024 /CNW/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today ...

Biocon Biologics Ltd. (BBL), a subsidiary of Biocon Limited, is a unique, fully integrated, global biosimilars company committed to transforming healthcare and transforming lives. It is ...